Posted on

cbd negative side effects

These trials will double the number of preexisting clinical trials that have been carried out for cannabidiol, and it’s just the beginning. Will some of the promising benefits of CBD prove wrong when tested clinically? Most likely. People are currently trying to treat countless conditions with CBD, and it’s likely that a few of them might not be any more effective than placebo when tested with clinical trials.

Side effects from dishonest CBD products

Want more? Sign up for our newsletter

When looking through the thousands of scientific articles referencing CBD, it’s very difficult to find any evidence of dangerous side effects or contraindications. However, widespread use of concentrated CBD is a very new phenomenon, and your safety is our priority.

What can these unreliable products contain?

Clinical evidence for CBD oil

Another review with meta-analysis of 104 studies evaluated cannabinoids for the treatment of chronic non-cancer pain. Within this review and analysis, the effect of cannabinoids on sleep was also examined. There was low-quality evidence of improved sleep.

Early research suggests that 160 mg of cannabidiol before bed significantly improves sleep duration compared to a placebo in patients with insomnia. Smaller doses did not have this effect. Also, patients did not feel drowsy the next morning morning.

A review of clinical trials of the effect of cannabinoids on sleep suggested that cannabinoids could improve sleep quality, decrease sleep disturbances, and decrease the time it takes to fall asleep. However there were many limiting factors such as a small number of people studied and they evaluated sleep within studies of other illnesses.

Does Oral CBD Help with Sleep?

CBD is the primary cannabinoid in hemp. It has various healing properties. For example, it seems to lessen inflammation, the body’s response to illness or injury. In this way, it may be helpful in treating many different diseases.

An app was used to measure changes in insomnia in over 400 people taking medical cannabis. The average symptom severity was reduced by 4.5 points on a 10-point scale, a significant improvement in insomnia.

Cannabinoid receptors are part of the complex endocannabinoid system (ECS). It regulates the release of neurotransmitters (chemicals that communicate between nerve cells) in the brain, as well as in other parts of the nervous system. The ECS responds to both types of cannabinoids, phyto- and endo-.

The body also produces natural cannabinoids, called endocannabinoids. Cannabinoids act on cannabinoid receptors.